J Hematol Oncol
AnemiaAntibodies, Monoclonal, HumanizedHemoglobins
Dr. David Allen Smith, MD
NPI1528061181
- Medicare services, 2019
- 14,882
- Part D claims, 2019
- 187
- Publications
- 5
- Clinical trials
- 10
- Industry payments
- $20,278
- Practice address
- 210 Se 136th Ave, Vancouver, WA 98684-6930
- Practice phone
- Call (360) 944-9889
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Compass Oncology
Multi-specialty group site · Vancouver, Washington
Find Dr. Smith's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. David Allen Smith is a hematologist and oncologist in Vancouver, Washington
Dr. Smith practices at Compass Oncology in Vancouver, Washington.
Dr. Smith's NPI, 1528061181, was assigned on May 27, 2005. Dr. Smith holds Washington license MD00031879.
NPI and contact details
- NPI
- 1528061181NPI Registry (opens in a new tab)
- NPI enumeration date
- May 27, 2005
- NPI status
- Active
- Practice phone
- (360) 944-9889
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. David Allen Smith practices at Compass Oncology in Vancouver, Washington
Dr. Smith's primary practice is Compass Oncology, at 210 Se 136th Ave, Vancouver, WA 98684-6930. The practice phone is (360) 944-9889.
- Compass Oncology210 Se 136th Ave, Vancouver, WA 98684-6930Phone(360) 944-9889
Sources: Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. David Allen Smith is affiliated with 1 site of care and 1 medical group
Dr. Smith's primary practice is Compass Oncology in Vancouver, Washington. The medical group on file is Compass Oncology.
Compass OncologyPrimary
Sources: Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dmand AI tracks the EHR system at Dr. David Allen Smith's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Smith practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Compass Oncology | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Smith practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. David Allen Smith is one of 348 hematologists and oncologists in Washington
Hematology and oncology is Dr. Smith's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Smith is licensed in Washington.
Specialties and state licenses
- Hematology and oncology, WashingtonPrimary
Hematologists and oncologists near Dr. Smith
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. David Allen Smith billed Medicare for 14,882 services in 2019
CMS data shows 14,882 Medicare services from Dr. Smith across 38 procedure codes in 2019. Medicare paid $93,569 for them. Every service was in an office.
Medicare services, 201914,882
Paid by Medicare$93,569
Procedure codes38
Dr. Smith's Medicare services by type, 2018 to 2019
- 2018
- 2019
- Drugs given in the office
- 2018: 52,8192019: 9,92881%
- Other services
- 2018: 6,6592019: 3,15853%
- Lab and pathology
- 2018: 1,6852019: 79553%
- Tests and treatments
- 2018: 1,2122019: 53056%
- Surgery
- 2018: 4812019: 22054%
- Office and hospital visits
- 2018: 4482019: 19457%
- Imaging
- 2018: 1232019: 5754%
Dr. Smith compared with the Washington median for hematologists and oncologists, 2019
- Dr. Smith
- Washington median
- Medicare services
- 14,882vs 58525.4 times
- Part D claims
- 187vs 28334% below
Medians across 310 hematologists and oncologists in Washington with Dmand AI profiles that report each measure.
Dr. Smith's most billed Medicare procedure codes, 2019
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Smith?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Smith and other hematologists and oncologists in Washington.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. David Allen Smith's patients have a median age of 67
Across all payers, Dmand AI patient panel data puts Dr. Smith's median patient age at 67, with 67% women.
Dr. Smith's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 67
Patient panel by sex, all payers
- Women67%
- Men33%
Source: Dmand AI Patient Panel Data
Dr. David Allen Smith wrote 187 Medicare Part D claims in 2019
In 2019, Dr. Smith wrote 187 Medicare Part D claims. They cover 7 drugs, with $4,477 in total drug cost. In 2018, CMS named 449 claims across 19 drugs.
Part D claims, 2019187
Drugs named by CMS7
Total drug cost$4,477
Dr. Smith's most prescribed drugs by claims, 2019
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2018 to 2019
- 2018
- 2019
- Claims for drugs CMS names
- 2018: 4492019: 18758%
Drugs named by CMS: 7 in 2019, 19 in 2018.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Smith by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. David Allen Smith has 5 publications on record
Dmand AI links 5 papers to Dr. Smith, published from 2014 to 2020. Dr. Smith's most frequent co-authors are Robert Matthew Jotte, MD, Lawrence E. Garbo, MD and Donald Anthony Richards, MD.
Papers5
Years published2014 to 2020
Dr. Smith's papers by year, 2014 to 2020
Dr. Smith's most frequent co-authors
- Robert Matthew Jotte, MD3 shared papers
- Lawrence E. Garbo, MD2 shared papers
- Donald Anthony Richards, MD2 shared papers
Recent publications by Dr. Smith
See who Dr. Smith researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Smith works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. David Allen Smith has worked on 10 clinical trials
Dmand AI links Dr. Smith to 10 clinical trials, 5 of them phase 1/2 studies. 1 is still active or recruiting. Conditions studied include Carcinoma, Bronchogenic, Small Cell Lung Carcinoma and Carcinoma, Medullary. G1 Therapeutics, Inc. sponsors the most, 2. Open Payments lists research payments to Dr. Smith that name 1 trial.
Clinical trials with Dr. Smith by phase
- NonePhase 1: no trials
- 5Phase 1/2: 5 trials
- 2Phase 2: 2 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Smith's trials
- Carcinoma, Bronchogenic
- Small Cell Lung Carcinoma
- Carcinoma, Medullary
- Carcinoma, Non-Small-Cell Lung
- Hematologic Neoplasms
Investigators on the most trials with Dr. Smith
- Allen L. Cohn, MD3 shared trials
- Ronald P. Harris, DO3 shared trials
- Sridhar Beeram, MD2 shared trials
Recent clinical trials with Dr. Smith
Leukemia, Myelomonocytic, ChronicMyelodysplastic-Myeloproliferative DiseasesAlvocidib Plus Decitabine (during dose escalation only) or Azacitidine
The Circulating Cell-free Genome Atlas Study (opens in a new tab)
Active, not recruiting
Small Cell Lung CarcinomaCarcinoma, BronchogenicPegzilarginasePembrolizumab
An Open-Label Study of Rovalpituzumab Tesirine in Subjects With Delta-Like Protein 3-Expressing Advanced Solid Tumors (opens in a new tab)
TerminatedPhase 1/2
Carcinoma, MedullaryCarcinoma, NeuroendocrineRovalpituzumab tesirineDexamethasone
Carcinoma, Non-Small-Cell LungCarcinoma, BronchogenicNivolumabPegilodecakin
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. David Allen Smith received $20,278 in industry payments from 2016 to 2019
CMS Open Payments shows 22 general payments to Dr. Smith from 8 drug and device companies from 2016 to 2019. Consulting fees make up the largest share, 96% of the total. Verastem, Inc. paid the most, $5,940. It also lists 2 research payments totaling $3,040 from 2017 to 2018, naming 1 clinical trial.
General payments to Dr. Smith by program year, 2016 to 2019
General payments to Dr. Smith by kind, 2016 to 2019
$20.3Kin total
- Consulting fees$19,46396%
- Food and beverage$6183%
- Travel and lodging$1711%
- Education$250%
Companies that paid Dr. Smith the most, 2016 to 2019
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. David Allen Smith's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. David Allen Smith
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. David Allen Smith's NPI number?
Dr. David Allen Smith's NPI number is 1528061181. It was assigned on May 27, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. David Allen Smith?
Dr. David Allen Smith is a hematologist and oncologist in Vancouver, Washington. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. David Allen Smith practice?
Dr. Smith practices at 210 Se 136th Ave, Vancouver, WA 98684-6930. Dr. Smith's primary practice is Compass Oncology in Vancouver, Washington.
What is Dr. David Allen Smith's office phone number?
The practice phone on file for Dr. Smith is (360) 944-9889.
What is Dr. David Allen Smith's medical license number?
Dr. Smith holds Washington license MD00031879.
What medical group is Dr. David Allen Smith part of?
Dr. Smith is linked to Compass Oncology.
Does Dr. David Allen Smith accept Medicare?
Yes. CMS data shows Dr. Smith billed Medicare for 14,882 services in 2019.
What services does Dr. David Allen Smith bill to Medicare?
In 2019, Dr. Smith's most billed Medicare services were injected or infused drug (J9267), medicare temporary code (Q9967) and injected or infused drug (J0185).
What drugs does Dr. David Allen Smith prescribe most?
In 2019 Medicare Part D data, Dr. Smith's most prescribed drugs by claims were Hydroxyurea, Oxycodone HCl and Acyclovir.
Has Dr. David Allen Smith received payments from drug or device companies?
CMS Open Payments shows $20,278 in general payments to Dr. Smith from 8 companies from 2016 to 2019. The largest total came from Verastem, Inc.
Show 3 more questionsShow fewer questions
How long has Dr. David Allen Smith been practicing?
Dr. Smith's NPI was assigned in 2005.
Does Dr. David Allen Smith do research?
Dmand AI links 5 publications to Dr. Smith, published from 2014 to 2020. Dr. Smith has worked on 10 clinical trials.
Who does Dr. David Allen Smith publish with?
Dr. Smith's most frequent co-authors are Robert Matthew Jotte, MD (3 shared papers), Lawrence E. Garbo, MD (2 shared papers) and Donald Anthony Richards, MD (2 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Washington by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card